Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D&T) Committee Meeting Results for: June 10, 2015

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Afrezza New Drug Initial Review Require Prior Approval Prior Approval Required
Bunavail New Drug Initial Review Require Prior Approval Prior Approval Required
Qudexy XR New Drug Initial Review Require Prior Approval Prior Approval Required
Toujeo New Drug Initial Review Require Prior Approval Prior Approval Required
Viekera Pak New Drug Appeal Require Prior Approval Prior Approval Required